Termo-crómio  Fabricantes, Comerciantes, Fornecedores

Metallisierwerk Peter Schreiber KG was established in 1923. Until the late 1940’s the company’s main business was decorative surface treatment. Starting in 1950 Peter Schreiber KG began treatment of “functional surfaces”, specializing in hard chrome plating and the mechanical treatment of hard chrome plated and metallic surfaces.
In 1988 Tfe-Lok® Peter Schreiber GmbH was founded, specializing in advanced technical solutions using its patented Tfe-Lok® -process. Today our company is one of the most efficient in this field and our expertise is useful to a variety of industries all over the world.

Providing products and services across the full pharmaceutical value chain, Midas Pharma is a mid-sized company with almost 200 highly qualified employees that provides a wealth of expertise while connecting companies, people and knowledge. As a catalyst for collaboration, we have been supporting our clients and partners unlock untapped potential for more than 30 years. Active in all major pharmaceutical markets, our affiliates serve as points of contact for our local customers as well as development and supply partners. They also provide local competence and networks.
Midas is active in sourcing, supplying and developing finished products, active ingredients and intermediates. In addition, we offer services in:
• Custom synthesis• Biotechnology• Finished product development• Finished product manufacturing• Regulatory affairs• Quality management• Patents and intellectual property• Business development and licensing.
We create value by offering a wealth of expertise while coordinating and connecting the complementary parts — people, knowledge and resources — to facilitate global pharmaceutical projects. For laboratory and production work, we cooperate with carefully selected specialist partners. This approach is the key to our flexibility in creating solutions through a wide array of services.

Evonik is one of the world's leading specialty chemicals companies.
Profitable growth and sustained value creation form the heart of our
strategy. Around 80 percent of sales come from leading market positions,
which we plan to expand further. We concentrate on high-growth
megatrends, especially health, nutrition, resource efficiency and
globalization.